Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase.
Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase.
复制标题
DOI:
10.1021/acsmedchemlett.2c00265
复制
发表时间:
2022-09-08
影响因子:
4.2
通讯作者:
Chen, Liqiang
中科院分区:
文献类型:
--
作者:
Jung, Eunkyung;Soto-Acosta, Ruben;Xie, Jiashu;Wilson, Daniel J.;Dreis, Christine D.;Majima, Ryuichi;Edwards, Tiffany C.;Geraghty, Robert J.;Chen, Liqiang
Taking advantage of the uniquely constricted active site of SARS-CoV-2 Nsp14 methyltransferase, we have designed bisubstrate inhibitors interacting with the SAM and RNA substrate binding pockets. Our efforts have led to nanomolar inhibitors including compounds 3 and 10. As a prototypic inhibitor, compound 3 also has an excellent selectivity profile over a panel of human methyltransferases. Remarkably, C-nucleoside 10 exhibits high antiviral activity and low cytotoxicity, leading to a therapeutic index (CC50/EC50) greater than 139. Furthermore, a brief metabolic profiling of these two compounds suggests that they are less likely to suffer from major metabolic liabilities. Moreover, computational docking studies point to protein–ligand interactions that can be exploited to enhance inhibitory activity. In short, discovery of inhibitor 10 clearly demonstrates that potent and selective anti-SARS-CoV-2 activity can be achieved by targeting the Nsp14 methyltransferase. Therefore, the current work strongly supports the continued pursuit of Nsp14 methyltransferase inhibitors as COVID-19 therapeutics.
登录
查看更多内容
DOI:
10.1073/pnas.2101161118
发表时间:
2021-06-15
影响因子:
11.1
作者:
Hsu JC;Laurent-Rolle M;Pawlak JB;Wilen CB;Cresswell P
通讯作者:
Cresswell P
影响因子:
6.7
作者:
Ahmed-Belkacem, Rostom;Sutto-Ortiz, Priscila;Debart, Francoise
通讯作者:
Debart, Francoise
影响因子:
3.7
作者:
Chen, Xiaoxi;Murawski, Anthony;Balimane, Praveen V.
通讯作者:
Balimane, Praveen V.
影响因子:
1.8
作者:
Liu, F;Austin, DJ
通讯作者:
Austin, DJ
影响因子:
1.8
作者:
Metobo, Sammy E.;Xu, Jie;Kim, Choung U.
通讯作者:
Kim, Choung U.